Literature DB >> 11711036

(-)-D-Deprenyl attenuates apoptosis in experimental brain ischaemia.

L Simon1, G Szilágyi, Z Bori, P Orbay, Z Nagy.   

Abstract

(-)-D-Deprenyl protects neurons from oxidative damage and helps to maintain the mitochondrial membrane potential by influencing intracellular anti-apoptotic oncoproteins, such as Bcl-2. The cellular rescue in the penumbra region by (-)-D-deprenyl administration was examined after permanent middle cerebral artery occlusion in rats. (-)-D-Deprenyl was given continuously following permanent middle cerebral artery occlusion. Two days later, the rats were killed and their infarct volumes were determined. Coronal brain sections were stained with terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate deoxyribonucleic acid (DNA) nick-end labelling (TUNEL) and caspase-3, TUNEL and anti-neuronal nuclei (NeuN) double labelling. Neural plasticity was characterized by growth-associated protein-43 (GAP-43) immunohistochemistry. A 1000 x 1000-microm region was sampled at both cortical margins of the TUNEL-positive area at its borders. The numbers of TUNEL-labelled and TUNEL-caspase-3-labelled cells decreased significantly. (-)-D-Deprenyl treatment increased the number of GAP-43-positive cells. We conclude that (-)-D-deprenyl reduced the number of affected cells and induced neuronal plasticity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711036     DOI: 10.1016/s0014-2999(01)01375-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury.

Authors:  Nina Kaludercic; Andrea Carpi; Roberta Menabò; Fabio Di Lisa; Nazareno Paolocci
Journal:  Biochim Biophys Acta       Date:  2010-09-24

2.  Rasagiline is neuroprotective in an experimental model of brain ischemia in the rat.

Authors:  Z Speiser; A Mayk; L Litinetsky; T Fine; A Nyska; E Blaugrund; S Cohen
Journal:  J Neural Transm (Vienna)       Date:  2006-12-21       Impact factor: 3.575

3.  Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats.

Authors:  Sara A Wahdan; Mariane G Tadros; Amani E Khalifa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-23       Impact factor: 3.000

4.  Efficacy, safety, and patient preference of monoamine oxidase B inhibitors in the treatment of Parkinson's disease.

Authors:  Bradley J Robottom
Journal:  Patient Prefer Adherence       Date:  2011-01-20       Impact factor: 2.711

5.  Elevated [11C]-D-deprenyl uptake in chronic Whiplash Associated Disorder suggests persistent musculoskeletal inflammation.

Authors:  Clas Linnman; Lieuwe Appel; Mats Fredrikson; Torsten Gordh; Anne Söderlund; Bengt Långström; Henry Engler
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

6.  Adjuvant potential of selegiline in attenuating organ dysfunction in septic rats with peritonitis.

Authors:  Cheng-Ming Tsao; Jhih-Gang Jhang; Shiu-Jen Chen; Shuk-Man Ka; Tao-Cheng Wu; Wen-Jinn Liaw; Hsieh-Chou Huang; Chin-Chen Wu
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.